FBA
IMGN

Front Barnett Associates’s Immunogen Inc IMGN Stock Holding History

Front Barnett Associates’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,190
Closed -$30K – 123
2016
Q3 		$30K Sell
11,190
-3,000
-21% -$8.72K 0.01% 117
2016
Q2 		$44K Sell
14,190
-2,500
-15% -$15.7K 0.01% 118
2016
Q1 		$142K Hold
16,690
– – 0.03% 115
2015
Q4 		$226K Sell
16,690
-1,000
-6% -$12.3K 0.05% 112
2015
Q3 		$170K Hold
17,690
– – 0.04% 112
2015
Q2 		$254K Hold
17,690
– – 0.05% 106
2015
Q1 		$158K Sell
17,690
-500
-3% -$3.62K 0.03% 116
2014
Q4 		$111K Sell
18,190
-2,500
-12% -$22.9K 0.02% 113
2014
Q3 		$219K Hold
20,690
– – 0.04% 108
2014
Q2 		$245K Hold
20,690
– – 0.05% 103
2014
Q1 		$309K Hold
20,690
– – 0.06% 87
2013
Q4 		$304K Sell
20,690
-1,500
-7% -$23.1K 0.06% 89
2013
Q3 		$378K Hold
22,190
– – 0.08% 80
2013
Q2 		$368K Buy
+22,190
New +$360K 0.08% 79

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Front Barnett Associates's IMGN Position: Q4 2016 in Review

Front Barnett Associates sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 11,190 shares — an estimated $30K sold.

Front Barnett Associates first reported a position in IMGN in Q2 2013 and held it in 14 quarters. The position peaked at $378K in Q3 2013. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • Front Barnett Associates reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
  • Front Barnett Associates sold 11,190 Immunogen Inc shares in Q4 2016, an estimated $30K.
  • Front Barnett Associates first reported a position in Immunogen Inc in Q2 2013 and held it in 14 quarters.
  • Front Barnett Associates's Immunogen Inc position peaked at $378K in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on Front Barnett Associates's 13F filing for Q4 2016, filed 24 Jan 2017.